Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study content with an access-denied message. The page chrome (header/footer) remains visible, indicating the record cannot be loaded at this time.
    Difference
    19%
    Check dated 2026-09-22T23:31:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows an updated platform revision from v3.6.6 to v3.7.0, indicating a software update. This update represents maintenance and potential UI or bug fixes and does not modify the study data or listed details.
    Difference
    0.0%
    Check dated 2026-09-15T22:09:56.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a minor software revision to the page. No content or user-facing features appear to be altered.
    Difference
    0.0%
    Check dated 2026-09-01T18:23:17.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The study's identifiers now include a line for '2018 ( U.S. NIH Grant/Contract )', indicating NIH funding for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:48:53.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a small internal update to the platform's rendering system.
    Difference
    0.0%
    Check dated 2026-08-11T20:18:58.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Investigator Inquiry Form was removed from the study page. This eliminates a direct contact option for investigators to inquire about participation or obtain study details through the page.
    Difference
    0.0%
    Check dated 2026-08-04T17:15:20.000Z thumbnail image

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.